RXi Pharmaceuticals Corp. Company Profile (NASDAQ:RXII)

About RXi Pharmaceuticals Corp.

RXi Pharmaceuticals Corporation is a clinical-stage ribonucleic acid (RNA) interference (RNAi) company developing therapeutics in dermatology and ophthalmology that address unmet medical needs. The Company's development programs are based on its self-delivering RNAi (sd-rxRNA) platform and Samcyprone, a topical immunomodulator. Its clinical development programs include RXI-109, an sd-rxRNA, for the treatment of dermal and ocular scarring, and Samcyprone for the treatment of such disorders as warts, alopecia areata, non-malignant skin tumors and cutaneous metastases of melanoma. Its pipeline is focused on approximately three areas, including dermatology, ophthalmology and cosmetic product development. Its RNAi therapies are designed to silence, or down-regulate, the expression of a specific gene that may be over-expressed in a disease condition and its immunotherapy agent treats diseases by inducing, enhancing or suppressing an immune response.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: RXII
CUSIP:

Key Metrics:

Previous Close: $1.94
50 Day Moving Average: $2.25
200 Day Moving Average: $2.35
52-Week Range: $1.26 - $6.49
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -1.50
P/E Growth: 0.00
Market Cap: $12.72M
Outstanding Shares: 6,559,000
Beta: 0.91

Profitability:

Return on Equity: -120.07%
Return on Assets: -99.19%

Debt:

Current Ratio: 4.10%
Quick Ratio: 4.10%

Additional Links:

Companies Related to RXi Pharmaceuticals Corp.:

Consensus Ratings for RXi Pharmaceuticals Corp. (NASDAQ:RXII) (?)

Ratings Breakdown:	1 Buy Rating
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$3.50 (80.41% upside)

Analysts' Ratings History for RXi Pharmaceuticals Corp. (NASDAQ:RXII)

Show:

Date	Firm	Action	Rating	Price Target	Details
6/7/2016	HC Wainwright	Initiated Coverage	Buy	$3.50

(Data available from 9/27/2014 forward)

Earnings History for RXi Pharmaceuticals Corp. (NASDAQ:RXII)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/10/2016
8/11/2016	Q216	($0.36)	($0.34)			View	Listen
5/13/2016	Q116	($0.45)	($0.34)	$34.00 million	$10.00 million	View	Listen
3/30/2016	Q415	($0.05)	($0.04)			View	Listen
11/12/2015	Q315	($0.04)	($0.04)			View	Listen
8/12/2015	Q215	($0.09)	($0.05)			View	Listen
5/13/2015	Q115	($0.10)	($0.13)			View	Listen
3/30/2015	Q414	($0.14)	($0.13)			View	N/A
11/13/2014	Q314	($0.22)	($0.17)			View	N/A
8/14/2014	Q214	($0.25)	($0.23)			View	N/A
5/14/2014	Q114	($0.31)	($0.32)			View	N/A
3/28/2014		($0.31)	$0.84			View	N/A
11/14/2012	Q312		($0.02)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for RXi Pharmaceuticals Corp. (NASDAQ:RXII)

Current Year EPS Consensus Estimate: $-1.40 EPS
Next Year EPS Consensus Estimate: $-1.29 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q2 2016	1	($0.05)	($0.05)	($0.05)
Q3 2016	1	($0.32)	($0.32)	($0.32)
Q4 2016	1	($0.23)	($0.23)	($0.23)
Q1 2017	1	($0.20)	($0.20)	($0.20)
Q2 2017	1	($0.20)	($0.20)	($0.20)
Q3 2017	1	($0.17)	($0.17)	($0.17)
Q4 2017	1	($0.17)	($0.17)	($0.17)

(Data provided by Zacks Investment Research)

Dividend History for RXi Pharmaceuticals Corp. (NASDAQ:RXII)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for RXi Pharmaceuticals Corp. (NASDAQ:RXII)

Insider Ownership Percentage: 3.96%
Institutional Ownership Percentage: 11.76%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
4/2/2015	Geert Cauwenbergh	CEO	Buy	5,000	$0.72	$3,600.00
2/17/2015	Geert Cauwenbergh	CEO	Buy	4,000	$1.17	$4,680.00
2/10/2015	Geert Cauwenbergh	CEO	Buy	2,000	$1.24	$2,480.00
1/22/2015	Robert J Bitterman	Director	Buy	5,000	$1.20	$6,000.00
1/20/2015	Geert Cauwenbergh	CEO	Buy	10,000	$1.03	$10,300.00
12/30/2014	Geert Cauwenbergh	CEO	Buy	2,500	$1.59	$3,975.00
10/13/2014	Geert Cauwenbergh	CEO	Buy	3,000	$1.68	$5,040.00
9/19/2014	Geert Cauwenbergh	CEO	Buy	4,500	$2.20	$9,900.00
9/16/2014	Geert Cauwenbergh	CEO	Buy	5,000	$2.08	$10,400.00
9/15/2014	Geert Cauwenbergh	CEO	Buy	10,000	$2.18	$21,800.00
7/15/2014	Geert Cauwenbergh	CEO	Buy	1,000	$2.50	$2,500.00
7/9/2014	Geert Cauwenbergh	CEO	Buy	1,400	$2.57	$3,598.00
7/2/2014	Geert Cauwenbergh	CEO	Buy	2,000	$2.86	$5,720.00
6/19/2014	Geert Cauwenbergh	CEO	Buy	2,000	$2.98	$5,960.00
6/9/2014	Geert Cauwenbergh	CEO	Buy	1,000	$3.05	$3,050.00
6/4/2014	Geert Cauwenbergh	CEO	Buy	2,000	$2.94	$5,880.00
10/31/2013	Geert Cauwenbergh	CEO	Buy	1,000	$3.17	$3,170.00
10/23/2013	Geert Cauwenbergh	CEO	Buy	1,000	$3.34	$3,340.00
10/9/2013	Geert Cauwenbergh	CEO	Buy	1,000	$3.15	$3,150.00
8/29/2013	Curtis Lockshin	Director	Buy	1,000	$3.70	$3,700.00

(Data available from 1/1/2013 forward)

Latest Headlines for RXi Pharmaceuticals Corp. (NASDAQ:RXII)

Date	Headline
	Penny Stock Investors are Growing Curious About RXi Pharmaceuticals Corporation (NASDAQ:RXII) - Duncan Research (NASDAQ:RXII) www.duncanindependent.com - September 27 at 7:01 PM
	Keen Investors Find News on RXi Pharmaceuticals Corporation (NASDAQ:RXII) - Duncan Research (NASDAQ:RXII) www.duncanindependent.com - September 24 at 6:24 PM
	RXi Pharmaceuticals to Present at the 16th Annual Biotech in Europe Forum for Global Partnering and (NASDAQ:RXII) www.biomedreports.com - September 19 at 11:42 AM
	RXi Pharmaceuticals to Present at the 16th Annual Biotech in Europe Forum for Global Partnering and Investment Conference (NASDAQ:RXII) finance.yahoo.com - September 19 at 11:42 AM
	RXi Pharma To Present At The Conference (NASDAQ:RXII) www.biospace.com - September 13 at 12:02 PM
	RXi Pharmaceuticals to Present at the 4th Targeting Ocular Disorders Conference - PR Newswire (press release) (NASDAQ:RXII) www.prnewswire.com - September 12 at 6:46 PM
	RXi Pharmaceuticals to Present at the 4th Targeting Ocular Disorders Conference (NASDAQ:RXII) finance.yahoo.com - September 12 at 11:51 AM
	ETF’s with exposure to RXi Pharmaceuticals Corp. : September 12, 2016 (NASDAQ:RXII) www.capitalcube.com - September 12 at 11:51 AM
	RXi Pharmaceuticals Corporation Selected to Present at Cavendish Global Health Impact Forum - PR Newswire (press release) (NASDAQ:RXII) www.prnewswire.com - September 8 at 6:50 PM
	RXi Pharmaceuticals to Present at the 9th Annual BioPharm America Conference (NASDAQ:RXII) business.itbusinessnet.com - September 7 at 10:48 AM
	RXi Pharmaceuticals Corporation Selected to Present at Cavendish Global Health Impact Forum (NASDAQ:RXII) finance.yahoo.com - September 7 at 10:48 AM
	RXi Pharmaceuticals to Present at the 9th Annual BioPharm America™ Conference - PR Newswire (press release) (NASDAQ:RXII) www.prnewswire.com - September 6 at 11:55 AM
	RXi Pharmaceuticals to Present at the 9th Annual BioPharm America™ Conference (NASDAQ:RXII) finance.yahoo.com - September 6 at 11:55 AM
	ETF’s with exposure to RXi Pharmaceuticals Corp. : September 1, 2016 (NASDAQ:RXII) www.capitalcube.com - September 1 at 10:18 AM
	Will RXI Pharmaceuticals Corporation (NASDAQ:RXII) Hit $25 Price Target? - Investor Newswire (NASDAQ:RXII) www.investornewswire.com - August 22 at 11:50 AM
	RXI Pharmaceuticals' (RXII) CEO Geert Cauwenbergh on Q2 2016 Results - Earnings Call Transcript (NASDAQ:RXII) seekingalpha.com - August 12 at 10:29 AM
	EARNINGS SUMMARY: Details of RXi Pharmaceuticals Corp. Q2 Earnings Report (NASDAQ:RXII) www.rttnews.com - August 11 at 10:33 AM
	RXi Pharmaceuticals Reports Second Quarter 2016 Financial Results and Highlights Recent Corporate Developments (NASDAQ:RXII) finance.yahoo.com - August 11 at 10:33 AM
	RXi Pharmaceuticals: Samcyprone Data At AAD (NASDAQ:RXII) www.investing.com - August 4 at 7:43 PM
	RXI Pharmaceuticals Corporation (RXII) Updated Price Targets - FTSE News (NASDAQ:RXII) www.ftsenews.co.uk - August 4 at 10:26 AM
	RXi Pharmaceuticals to Webcast Second Quarter 2016 Financial Results on Thursday, August 11, 2016 (NASDAQ:RXII) finance.yahoo.com - July 28 at 7:02 AM
	RXi Pharmaceuticals to Present at the 2016 Summer Meeting of the American Academy of Dermatology - PR Newswire (press release) (NASDAQ:RXII) www.prnewswire.com - July 21 at 10:05 AM
	RXi Pharmaceuticals to Present at the 2016 Summer Meeting of the American Academy of Dermatology (NASDAQ:RXII) finance.yahoo.com - July 21 at 7:02 AM
	ETF’s with exposure to RXi Pharmaceuticals Corp. : July 20, 2016 (NASDAQ:RXII) www.capitalcube.com - July 20 at 12:51 PM
	Rxi Pharmaceuticals Corporation (NASDAQ:RXII) Shorts Decreased by 5.68% After Short Covering - Press Telegraph (NASDAQ:RXII) presstelegraph.com - July 19 at 8:21 AM
	Strong Sell Calls For RXI Pharmaceuticals Corporation (NASDAQ:RXII) At 0 - Investor Newswire (NASDAQ:RXII) www.investornewswire.com - July 17 at 6:38 PM
	Shares Moving Down on the Week: RXi Pharmaceuticals Corporation (NASDAQ:RXII) - Engelwood Daily (NASDAQ:RXII) www.engelwooddaily.com - July 17 at 11:19 AM
	Rxi Pharmaceuticals Corp Sentiment Improves on Better Stock Potential - Press Telegraph (NASDAQ:RXII) presstelegraph.com - July 15 at 12:27 PM
	Cincinnati Bell Inc. (NYSE:CBB) increased 4.39%: RXi Pharmaceuticals Corporation (NASDAQ:RXII), Magellan ... - KC Register (NASDAQ:RXII) www.kcregister.com - July 12 at 11:37 AM
	Is $25 Within Reach For RXI Pharmaceuticals Corporation (NASDAQ:RXII)? - Investor Newswire (NASDAQ:RXII) www.investornewswire.com - July 10 at 6:28 PM
	Brokers Issue Average Price Target Of 4.08 On RXI Pharmaceuticals Corporation (RXII) - Fiscal Standard (NASDAQ:RXII) www.fiscalstandard.com - July 10 at 11:14 AM
	Rxi Pharmaceuticals Corporation (NASDAQ:RXII) Shorted Shares Decreased By 5.68% - Press Telegraph (NASDAQ:RXII) presstelegraph.com - July 7 at 7:19 PM
	Share Volatility in Focus: RXi Pharmaceuticals Corporation (NASDAQ:RXII) - Engelwood Daily (NASDAQ:RXII) www.engelwooddaily.com - July 6 at 11:51 AM
	Company Stock Lower on the Week RXi Pharmaceuticals Corporation (NASDAQ:RXII) - Engelwood Daily (NASDAQ:RXII) www.engelwooddaily.com - July 3 at 11:22 AM
	Strong Sell Calls Recommendations For RXI Pharmaceuticals Corporation (NASDAQ:RXII) At 0 - Investor Newswire (NASDAQ:RXII) www.investornewswire.com - June 27 at 11:23 AM
	Share Volatility Check for: RXi Pharmaceuticals Corporation (NASDAQ:RXII) - Press Telegraph (NASDAQ:RXII) presstelegraph.com - June 24 at 7:19 PM
	Strong Buy Calls Count For RXI Pharmaceuticals Corporation (NASDAQ:RXII) At 2 - Investor Newswire (NASDAQ:RXII) www.investornewswire.com - June 21 at 11:34 AM
	This Weeks Broker Views For RXI Pharmaceuticals Corporation (RXII) - Fiscal Standard (NASDAQ:RXII) www.fiscalstandard.com - June 21 at 11:34 AM
	Trend Of Rating Given To RXI Pharmaceuticals Corporation (NASDAQ:RXII) - Investor Newswire (NASDAQ:RXII) www.investornewswire.com - June 13 at 10:11 AM
	RXi Pharmaceuticals Corp. :RXII-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 (NASDAQ:RXII) www.capitalcube.com - June 6 at 12:11 PM
	Next Weeks Broker Price Targets For RXI Pharmaceuticals Corporation (RXII) - Share Trading News (NASDAQ:RXII) www.sharetrading.news - May 31 at 7:19 AM
	Rxi Pharmaceuticals Corporation (NASDAQ:RXII) Sellers Increased By 13.42% Their Shorts - HNN (NASDAQ:RXII) hintsnewsnetwork.com - May 30 at 8:05 AM
	RXI Pharmaceuticals Corporation (NASDAQ:RXII) Closes At $2.17 - Investor Newswire (NASDAQ:RXII) www.investornewswire.com - May 27 at 10:19 PM
	Rxi Pharmaceuticals Corporation (NASDAQ:RXII) Shorts Decreased by 21.16% After Short Covering - Wall Street Hints and News (NASDAQ:RXII) hintsnewsnetwork.com - May 26 at 8:04 AM
	Preview of HC Stock's Movement: Immunomedics, Inc. (NASDAQ:IMMU), RXi Pharmaceuticals Corp (NASDAQ:RXII) - share market updates (press release) (NASDAQ:RXII) sharemarketupdates.com - May 23 at 9:43 AM
	After Last Week What Do Analysts Think Of RXI Pharmaceuticals Corporation (RXII) - Share Trading News (NASDAQ:RXII) www.sharetrading.news - May 22 at 9:34 PM
	Revenue Update on RXi Pharmaceuticals Corp(NASDAQ:RXII) - Trade Calls (NASDAQ:RXII) www.tradecalls.org - May 20 at 9:58 PM
	RXI PHARMACEUTICALS CORP Financials (NASDAQ:RXII) finance.yahoo.com - May 20 at 1:04 PM
	Alpha One Assigns Impact Score Of 0 To RXI Pharmaceuticals Corporation (NASDAQ:RXII) - RealistInvestor.com (NASDAQ:RXII) www.realistinvestor.com - May 19 at 9:58 PM
	HC Stocks in Hub: CTI BioPharma Corp (CTIC), CytRx Corporation (CYTR), RXi Pharmaceuticals Corp (RXII) - share market updates (press release) (NASDAQ:RXII) sharemarketupdates.com - May 12 at 5:09 PM